Collegium to Participate in Upcoming Investor Conferences
Collegium schedules September webcasts for its appearances at Morgan Stanley and H.C. Wainwright investor conferences.
Rhea-AI Summary
Collegium Pharmaceutical (COLL) will participate in two upcoming investor conferences in New York. Management joins the Morgan Stanley 24th Annual Global Healthcare Conference for a fireside chat on September 15, 2026, at 4:05 p.m. ET, and presents at the H.C. Wainwright 28th Annual Global Investment Conference on September 16, 2026, at 9:00 a.m. ET. Live webcasts and 90-day replays of both events will be accessible through the Investors section of the company’s website.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that its management will participate in the following investor conferences:
Morgan Stanley 24th Annual Global Healthcare Conference
Fireside Chat Date and Time: Tuesday, September 15, 2026, at 4:05 p.m. ET
New York, NY
H.C. Wainwright 28th Annual Global Investment Conference
Presentation Date and Time: Wednesday, September 16, 2026, at 9:00 a.m. ET
New York, NY
Live webcasts of the presentations will be available via the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcasts will be archived on the Company's website for 90 days following the presentations.
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.
With a portfolio of differentiated ADHD medications, anchored by JORNAY PM® (methylphenidate HCl) and AZSTARYS® (serdexmethylphenidate and dexmethylphenidate), and an established leadership position in responsible pain management, Collegium leads with the scientific rigor and commercial expertise to deliver treatment options around how people live their lives. For more information, please visit collegiumpharma.com or find us on LinkedIn.
Investor Contact:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com
Media Contact:
Jessica Cotrone
Senior Vice President, Corporate Communications & Corporate Affairs
communications@collegiumpharma.com
FAQ
How can investors access the live webcasts of Collegium's conference appearances?
Live webcasts of Collegium's fireside chat at the Morgan Stanley conference and its presentation at the H.C. Wainwright conference will be available through the Investors section of the company’s website at https://ir.collegiumpharma.com.
Will replays of the Collegium conference webcasts be available after the events?
Yes. Replays of the webcasts from both investor conferences will be archived on Collegium’s website for 90 days following the presentations.
When and where is Collegium's fireside chat at the Morgan Stanley Global Healthcare Conference?
The fireside chat is scheduled for Tuesday, September 15, 2026, at 4:05 p.m. ET at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY.
When and where is Collegium's presentation at the H.C. Wainwright Global Investment Conference?
The presentation is scheduled for Wednesday, September 16, 2026, at 9:00 a.m. ET at the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY.